Free Trial

FORA Capital LLC Acquires Shares of 4,833 Cabot Co. (NYSE:CBT)

Cabot logo with Basic Materials background

FORA Capital LLC purchased a new position in Cabot Co. (NYSE:CBT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,833 shares of the specialty chemicals company's stock, valued at approximately $441,000.

A number of other large investors also recently modified their holdings of CBT. R Squared Ltd bought a new position in Cabot in the 4th quarter valued at $26,000. EverSource Wealth Advisors LLC raised its holdings in shares of Cabot by 37.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after acquiring an additional 219 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Cabot by 10.7% in the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after acquiring an additional 130 shares in the last quarter. Manchester Capital Management LLC boosted its position in shares of Cabot by 1,685.1% during the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after acquiring an additional 1,584 shares during the last quarter. Finally, KBC Group NV grew its holdings in shares of Cabot by 43.1% during the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock worth $187,000 after purchasing an additional 616 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. JPMorgan Chase & Co. reduced their target price on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research note on Friday, February 21st. StockNews.com lowered Cabot from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Finally, UBS Group cut their target price on Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research note on Monday, April 7th.

Get Our Latest Stock Analysis on CBT

Cabot Trading Up 2.9%

Shares of NYSE CBT traded up $2.15 during mid-day trading on Monday, hitting $76.12. The stock had a trading volume of 595,657 shares, compared to its average volume of 403,452. The firm has a market cap of $4.13 billion, a P/E ratio of 10.11, a price-to-earnings-growth ratio of 0.74 and a beta of 0.91. The business has a 50 day moving average price of $80.02 and a two-hundred day moving average price of $90.78. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. Cabot Co. has a 1 year low of $71.64 and a 1 year high of $117.46.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.86 by $0.04. The company had revenue of $936.00 million for the quarter, compared to the consensus estimate of $1.02 billion. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Cabot's revenue was down 8.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.78 EPS. On average, equities analysts anticipate that Cabot Co. will post 7.57 EPS for the current fiscal year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be issued a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 30th. This is a positive change from Cabot's previous quarterly dividend of $0.43. This represents a $1.80 annualized dividend and a yield of 2.36%. Cabot's dividend payout ratio is 23.29%.

Cabot Company Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Featured Articles

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines